Similar Articles

Magnesium for migraine prophylaxis: A Double-Blind Plascebo Controlled Trial

Şeref DEMİRKAYA, Okay VURAL, Zeki GÖKÇİL, Erdal EROĞLU, Fatih ÖZDAĞ, Muzaffer YARDIM

Issue: 1997, Volume 3 - Issue 3-4
0 149

Migraine and Epilepsy

Günfer GÜRER, Serap SAYGI, Abdurrahman CİĞER

Issue: 1997, Volume 3 - Issue 1-2
0 248

The Effectiveness of Subcutaneons Sumatriptan in the Treatment Migrain Attacks

Tahir K. YOLDAŞ, Abdullah GÜNEN, Yılmaz SADIKOĞLU, Refik A. SARI, Mehmet MEŞHUR, Emin KURT

Issue: 1996, Volume 2 - Issue 1-2
0 146

Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.

Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA

Issue: 1995, Volume 1 - Issue 3
0 152

Hypothalamic-Pitutary-Adrenal Axis Investigation in Migraneous Patients

Mehmet ZARİFOĞLU, Asuman ALİ, İsmail Hakkı ULUS, Mustafa BAKAR, İbrahim BORA, Ömer Faruk TURAN, Sadık SADIKOĞLU, Erhan OĞUL

Issue: 1995, Volume 1 - Issue 2
0 151

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 288

The wear-off phenomenon of repeated botulinum toxin injection for chronic migraine treatment: A retrospective study

Emir Ruşen, Gaye Hafez, Yeşim Tunç

DOI: 10.55697/tnd.2024.18

Issue: 2024, Volume 30 - Issue 1
921 534